 ST. LOUIS, Feb. 25, 2021 GLOBE NEWSWIRE -- Stereotaxis NYSE: STXS, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results for the fourth quarter and full year ended December 31, 2020. 